Differential role of pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction

Anesthesiology

Volumn 111, Issue 6, 2009, Pages 1257-1264

  Stumpner, Jan ^a   Redel, Andreas ^a   Kellermann, Anna ^a   Lotz, Christopher A ^a   Blomeyer, Christoph A ^a   Smul, Thorsten M ^a   Kehl, Franz ^a   Roewer, Norbert ^b   Lange, Markus ^a  

^a Klinikum Karlsruhe   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 3 CYANO 4 PHENYL 6 (3 BROMO 6 HYDROXYPHENYL)PYRIDINE; CYTOCHROME C; DESFLURANE; DIMETHYL SULFOXIDE; EVANS BLUE; PENTOBARBITAL; PROTEIN BAD; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE INHIBITOR; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; DRUG DERIVATIVE; INHALATION ANESTHETIC AGENT; ISOFLURANE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART MUSCLE; HEART RATE; METABOLISM; PATHOLOGY; PHYSIOLOGY; STATISTICAL ANALYSIS;

ANESTHETICS, INHALATION; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; BLOOD PRESSURE; BLOTTING, WESTERN; CYTOCHROMES C; DATA INTERPRETATION, STATISTICAL; ENZYME ACTIVATION; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-PIM-1; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 73449146667     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181bdf9f4     Document Type: Article

References (40)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136
2. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K-ATP channel: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87: 361-370
3. 1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. ANESTHESIOLOGY 2006; 105:503-510
4. Smul TM, Lange M, Redel A, Burkhard N, Roewer N, Kehl F: Desflurane-induced preconditioning against myocardial infarction is mediated by nitric oxide. ANESTHESIOLOGY 2006; 105:719-725
5. Redel A, Lange M, Jazbutyte V, Lotz C, Smul TM, Roewer N, Kehl F: Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning. Anesth Analg 2008; 106:384-391
6. Tong H, Chen W, Steenbergen C, Murphy E: Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 2000; 87:309-315
7. Raphael J, Rivo J, Gozal Y: Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling. Br J Anaesth 2005; 95:756-763
8. Raphael J, Abedat S, Rivo J, Meir K, Beeri R, Pugatsch T, Zuo Z, Gozal Y: Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006; 318:186-194
9. Suleman N, Somers S, Smith R, Opie LH, Lecour SC: Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 2008; 79:127-133
10. Mocanu MM, Bell RM, Yellon DM: PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 2002; 34:661-668
11. Muraski JA, Rota M, Misao Y, Fransioli J, Cottage C, Gude N, Esposito G, Delucchi F, Arcarese M, Alvarez R, Siddiqi S, Emmanuel GN, Wu W, Fischer K, Martindale JJ, Glembotski CC, Leri A, Kajstura J, Magnuson N, Berns A, Beretta RM, Houser SR, Schaefer EM, Anversa P, Sussman MA: Pim-1 regulates cardiomy-ocyte survival downstream of Akt. Nat Med 2007; 13:1467-1475
12. Muraski JA, Fischer KM, Wu W, Cottage CT, Quijada P, Mason M, Din S, Gude N, Alvarez RJr, Rota M, Kajstura J, Wang Z, Schaefer E, Chen X, MacDonnel S, Magnuson N, Houser SR, Anversa P, Sussman MA: Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sci U S A 2008; 105:13889-13894
13. Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, Welch S, Schaefer E, Walsh K, Rosenzweig A, Torella D, Nurzynska D, Kajstura J, Leri A, Anversa P, Sussman MA: Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 2004; 94:884-891
14. Tsujita Y, Muraski J, Shiraishi I, Kato T, Kajstura J, Anversa P, Sussman MA: Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2006; 103:11946-11951
15. Bachmann M, Moroy T: The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005; 37:726-730
16. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ: Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylat-ing it on the Ser112 gatekeeper site. FEBS Lett 2004; 571:43-49
17. Bayne K: Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 1996; 39:199, 208-211
18. Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, Eltzschig H, Roewer N, Kehl F: Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 2008; 233:84-93
19. Eckle T, Grenz A, Kohler D, Redel A, Falk M, Rolauffs B, Osswald H, Kehl F, Eltzschig HK: Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 2006; 291:H2533-40
20. Cheney IW, Yan S, Appleby T, Walker H, Vo T, Yao N, Hamatake R, Hong Z, Wu JZ: Identification and structure-activity relationships of substituted pyri-dones as inhibitors of Pim-1 kinase. Bioorg Med Chem Lett 2007; 17:1679-1683
21. Sonner JM, Gong D, Eger EI: Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg 2000; 91:720-726
22. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997; 275:1132-1136
23. Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, Head BP, Hagiwara Y, Ishikawa Y, Miyanohara A, Patel PM, Insel PA, Patel HH, Roth DM: Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 2008; 118:1979-1988
24. Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK: Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 2008; 118:166-175
25. Lange M, Smul TM, Redel A, Lotz C, Jazbutyte V, Schnupp V, Roewer N, Kehl F: Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: Metoprolol blocks desflurane-induced preconditioning. ANESTHESIOLOGY 2008; 109:72-80
26. 2-adrenergic receptors, protein kinase A, and calcium/calmod-ulin-dependent protein kinase II. ANESTHESIOLOGY 2009; 110:516-528
27. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A: The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999; 18:4022-4031
28. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91:231-241
29. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN: Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003; 284:H456-63
30. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A: Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104:330-335
31. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001; 280:H2313-20
32. Imahashi K, Schneider MD, Steenbergen C, Murphy E: Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res 2004; 95: 734-741
33. Murphy E, Steenbergen C: Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88:581-609
34. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA: Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/ reperfusion. J Biol Chem 2001; 276:30724-30728
35. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-1228
36. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275:1129-1132
37. Bossy-Wetzel E, Newmeyer DD, Green DR: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17:37-49
38. Loop T, Dovi-Akue D, Frick M, Roesslein M, Egger L, Humar M, Hoetzel A, Schmidt R, Borner C, Pahl HL, Geiger KK, Pannen BH: Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. ANESTHESIOLOGY 2005; 102:1147-1157
39. West MB, Rokosh G, Obal D, Velayutham M, Xuan YT, Hill BG, Keith RJ, Schrader J, Guo Y, Conklin DJ, Prabhu SD, Zweier JL, Bolli R, Bhatnagar A: Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation 2008; 118:1970-1978
40. Maxwell MP, Hearse DJ, Yellon DM: Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21:737-746